Advanced Medical Solutions Group PLC on Monday announced pre-market approval in the US for its fixation device LuquiBandFix8, to be used during hernia surgery.

The Cheshire, England-based developer and maker of tissue-healing technology said the approval from the US Food & Drug Administration ‘was granted ahead of schedule and seven months after submission, a significant achievement for the company’s first PMA application,’ it said.

The approval represents the chance to enter a new addressable market estimated to be worth around $200 million, AMS said.

Advanced Medical Solutions shares were 2.7% higher at 240.32 pence each in London on Monday morning.

Copyright 2023 Alliance News Ltd. All Rights Reserved.